FIELD: veterinary medicine.
SUBSTANCE: invention relates to the field of microbiology and veterinary medicine. Vaccine includes preparations of inactivated whole cells P.gulae B43, P. salivosa B104 and O. denticanis B106 pharmaceutically acceptable carrier. Vaccine is effective against animal paradontosis.
EFFECT: method of treating or preventing animals-companions' paradontosis with help of this vaccine and set containing it are also discovered.
15 cl, 38 dwg, 9 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
FLU VIRUS, CAPABLE OF INFECTING CANIDAE AND ITS APPLICATION | 2006 |
|
RU2520081C2 |
INFLUENZA INFECTING DOGS AND USE THEREOF | 2014 |
|
RU2711807C2 |
PCV2B DIVERGENT VACCINE COMPOSITION AND METHODS OF USE | 2014 |
|
RU2662685C2 |
RECOMBINANT ATTENUATED MICROORGANISMS CLOSTRIDIUM AND VACCINE | 2007 |
|
RU2445364C2 |
ESSENTIALLY NON-TOXIC MUTEIN OF Clostridium perfringens ALPHA TOXIN AND NUCLEIC ACID MOLECULE CODING SAME | 2007 |
|
RU2593945C2 |
OSPA CHIMERIC GENES, PROTEINS AND METHODS FOR USE THEREOF | 2011 |
|
RU2583289C2 |
PROBIOTIC STRAIN Bifidobacterium longum, PROBIOTIC COMPOSITION AND USE OF STRAIN Bifidobacterium longum | 2008 |
|
RU2466185C2 |
COMBINATION VACCINE PCV/MYCOPLASMA HYOPNEUMONIAE/PRRS (PCV/MYCOPLASMA HYOPNEUMONIAE/PRRS COMBINATION VACCINE) | 2013 |
|
RU2644256C2 |
CLOSTRIDIAL TOXIN NetB | 2008 |
|
RU2474587C2 |
MYCOPLASMA HYOPNEUMONIAE VACCINE | 2013 |
|
RU2644254C2 |
Authors
Dates
2009-08-20—Published
2005-03-21—Filed